跳至主要内容
临床试验/JPRN-UMIN000026185
JPRN-UMIN000026185已完成未知

Effect of oral hypoglycemic agent for postprandial hyperglycemia administered two times daily on glycemic control in patients with type 2 diabetes with Mitiglinide / Voglibose combination tablets - Effect of twice daily administration on glycemic control in patients with type 2 diabetes with Mitiglinide / Voglibose combination tablets.

St.Marianna University School of Medicine0 个研究点目标入组 50 人开始时间: 2017年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with contraindications against the use of mitiglinide calcium hydrate tablets and mitiglinide calcium hydrate/voglibose combimation tablets based on their package inserts. 2) Patients who had taken sulfonylureas, GLP-1 receptor agonists,glinide,a-GI, SGLT-2 inhibitors, insulin within 8 weeks (56 days) before the start of the study 3) Excessive drinkers 4) Patients with severe diabetic microangiopathy 5) Patients with severe liver / kidney function decline 6) Patients with severe heart disease 7) Patients with severe hypertension combined 8) Patients with open surgery or previous bowel obstruction 9)Patients who were judged to be ineligible to be ineligible by the investigator or sub-investigator

研究者

相似试验